Cargando…
Use of firocoxib for the treatment of equine osteoarthritis
This review presents the pathogenesis and medical treatment of equine osteoarthritis (OA), focusing on firocoxib. Inhibition of prostaglandin E(2) remains a fundamental treatment for decreasing clinical symptoms (ie, pain and lameness) associated with OA in horses. Nonsteroidal anti-inflammatory dru...
Autores principales: | Donnell, Josh R, Frisbie, David D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337192/ https://www.ncbi.nlm.nih.gov/pubmed/32670856 http://dx.doi.org/10.2147/VMRR.S70207 |
Ejemplares similares
-
The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis
por: Vijarnsorn, Monchanok, et al.
Publicado: (2019) -
Correction to: The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis
por: Vijarnsorn, Monchanok, et al.
Publicado: (2020) -
Analgesic efficacy of oral firocoxib in ovariohysterectomized cats
por: Phuwapattanachart, Prangtip, et al.
Publicado: (2017) -
Development of Two Innovative Performance-Based Objective Measures in Feline Osteoarthritis: Their Reliability and Responsiveness to Firocoxib Analgesic Treatment
por: Delsart, Aliénor, et al.
Publicado: (2022) -
Cutaneous adverse drug reaction in a dog following firocoxib treatment
por: Geum, Migyeong, et al.
Publicado: (2021)